(Q53487800)
Statements
Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee (English)
Moyle GJ
Antunes F
Smith D
Harris R
Warburg M